CRN Asks International Trade Commission to Reject Amarin ’s Omega-3 Complaint, Citing Legal Deficiencies, Harm to Public Interest

In two filings submitted to the International Trade Commission, CRN argued that Amarin was "financially motivated" to expand its near monopoly over a subset of omega-3 products; if successful, CRN says, Amarin's complaint would make it much more difficult and costly for consumers to access those products. (Source: CancerNetwork)

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2i4XCef
via IFTTT